Status In progress
Process STA
ID number 991

Provisional Schedule

Appraisal consultation 06 November 2017 - 27 November 2017
Committee meeting: 2 12 December 2017
Expected publication 28 March 2018

Project Team

Project lead Stephanie Yates

Email enquiries

Consultees

Companies sponsors Bayer (regorafenib)
Others Department of Health
  NHS England
  Welsh Government
Patient carer groups British Liver Trust
Professional groups Association of Cancer Physicians
  British Association of the Study of the Liver
  Cancer Research UK
  Royal College of Physicians
  Royal College of Radiologists

Commentators

Associated public health groups None
Comparator companies None
Evidence review group School of Health and Related Research (ScHARR)
General commentators All Wales Therapeutics and Toxicology Centre
  British National Formulary
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Welsh Health Specialised Services Committee
Relevant research groups Institute of Cancer Research
  National Cancer Research Institute
  National Institute for Health Research

Timeline

Key events during the development of the guidance:

Date Update
12 October 2017 Committee meeting: 1
15 May 2017 Invitation to participate
22 July 2016 Referral

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance